Inhibition of nuclear ribonuclease activity during transcription in vitro by aurintricarboxylic acid and vanadyl riboncleoside complexes.
D000818:Animals; D001312:Aurintricarboxylic Acid / Q000494:pharmacology*; D002467:Cell Nucleus / Q000378:metabolism*; D003509:Cyclohexanecarboxylic Acids / Q000494:pharmacology*; D012321:DNA-Directed RNA Polymerases / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D012313:RNA / Q000096:biosynthesis; D051381:Rats; D012260:Ribonucleases / Q000037:antagonists & inhibitors*; D012263:Ribonucleosides / Q000494:pharmacology*; D014158:Transcription, Genetic / Q000187:drug effects*; D014639:Vanadium; D014981:Xenopus
D003509:Cyclohexanecarboxylic Acids; D012263:Ribonucleosides; D014639:Vanadium; D001312:Aurintricarboxylic Acid; D012313:RNA; D012321:DNA-Directed RNA Polymerases; D012260:Ribonucleases